RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:USA Inflation Reduction Act (IRA) 2022 Re: Biotech and ChinaThe posts are all relevant to ONCY, the 13 years of market exclusivity at pelareorep would be granted as a biologic under the Inflation Reduction Act passed in 2022, and how China had employed McKinsey to try to usurp and thwart US innovation, for their own economic benefit. The actions of Dominic Barton were ones that McKinsey is now being held liable for by the US government, such as their global conflictrs of interest and advisement of China and Purdue Pharma.
Now McKinsey is advising that it is " Revamping Its China Operations Amid New Risks" and is cutting hundreds from its China workforce, as it trims state-linked clients and revises its 'win-at-all costs' and "accelerant" business strategy for tougher times. This is happening amid public inquiries, increased government scrutiny, and diminishing public perception over its complicit business practices.